Pharvaris b.v.

Major-Pharmaceuticals

PHVS


Executive/
Director

Price

  • Last Close
  • $ 17.31
    $ -0.81 -4.47 %
    Aug 29, 2024
  • 52-Week High/Low
  • $32.07 - $15.2
  • YTD
  • -38.3%

  • Trading Volume
  • 1,812
  • Market Cap Full
  • $ 585.4M
  • Shares Outstanding
  • 33.8M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - 26% -30.5% -17.6%
Q2 - - - - - - -33.4% 21.9% 100.9% -
Q3 - - - - - - -4.8% -65.3% 32.9% -
Q4 - - - - - - -18.8% 46.7% 51.6% -
J F M A M J J A S O N D
2024 6.6% -23.3% 0.7% -6.4% - - - - - - - -
2023 -20% -7.7% -5.9% 19.6% -8.6% 83.7% 8.2% 20.6% 1.8% -18.5% 1.2% 63%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-22%149%-38%

Earnings

2021 2022 2023
Q1 -0.8 -0.54 -0.72
Q2 -1.13 -0.4 -0.69
Q3 -0.46 -0.25 -0.63
Q4 0.73 -1.20 -
A -1.7 -2.39 -2.04

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022
Mar - - -
Jun - - -
Sep - - -
Dec 4.9 33.2 33.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 8.3 4.9 -29 - -
Equity multiplier - - - - -